Optimization of fluorescent substrates for ADAM17 and their utility in the detection of diabetes

Anal Biochem. 2023 Nov 15:681:115337. doi: 10.1016/j.ab.2023.115337. Epub 2023 Sep 30.

Abstract

ADAM17 (a disintegrin and metalloproteinase 17) is a sheddase that releases various types of membrane-associated proteins, including adhesive molecules, cytokines and their receptors, and inflammatory mediators. Evidence suggests that the enzyme is involved in the proteolytic cleavage of antiaging transmembrane protein Klotho (KL). What is more, reduced serum and urinary KL levels are observed in the early stages of chronic kidney disease. This study aimed to optimise the ADAM17 specific and selective fluorescent substrates. Then, the obtained substrate was used to detect the enzyme in urine samples of patients diagnosed with diabetes. It turned out that in all cases we were able to detect proteolytic activity, which was the opposite of the healthy samples.

Keywords: ADAM17; Combinatorial chemistry; Diabetes; Fluorogenic peptides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM17 Protein
  • Diabetes Mellitus* / diagnosis
  • Humans
  • Membrane Proteins
  • Proteolysis

Substances

  • ADAM17 Protein
  • Membrane Proteins
  • ADAM17 protein, human